Trading on split-adjusted basis will begin at market open on July 29, 2025. This adjustment is expected to help Silexion ...

Inside the packed auditorium of Government College for Women, M.A. Road, Srinagar, more than a hundred faculty members gathered Tuesday m ...

With the signing of the Sunshine Genetics Act, Florida has positioned itself as a national leader in pediatric genetic ...

Investing.com -- Gain Therapeutics Inc (NASDAQ: GANX) stock fell 11% after the clinical-stage biotechnology company announced plans for an underwritten public offering of common stock and warrants to ...

From the internet to the ozone layer, AI to the human genome, UC scientists have turned federal research funding into history ...

Combined Company to Trade on Nasdaq Under Ticker "IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock.

Charles River Laboratories International, Inc. CRL expands its products and services across the drug discovery and early-stage development continuum through targeted partnerships and acquisitions.

Combined Company to Trade on Nasdaq Under Ticker "IMA" Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc.

Dr. Lotan graduated with high honors from the University of Texas at Austin and with honors from Baylor College of Medicine in Houston. He trained in general surgery and urology at UT Southwestern ...

By harnessing cloud-native elasticity and global reach, the BullFrog Data Networks Solutions Library enables lightning-fast deployment of the bfLEAP™ platform. Clients working with BullFrog AI can now ...

Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.